Symptom Advice .com » ipt

How to Find The Symptoms of Prostate Cancer and Prevention

Symptom Advice — Fri, 06 May 2011 08:51:18 +0000

Many elderly men who have trouble urinating due to prostate enlargement (non cancer). In some men this enlargement was followed by the growth of cancer.

[removed]// ”);//]]>// ]]>[removed][removed][removed][removed]// [removed][removed][removed]

Meanwhile, prostate cancer occurs when prostate cells grow faster than normal conditions to form lumps or tumors that have a malignancy. This cancer is most common in men, particularly those aged over 65 years. Prostate cancer is the most common cancer in men. This even is the second most deadly cancer.

<a rel=”nofollow” onclick=”javascript:_gaq.push(['_trackPageview', '/outgoing/article_exit_link']);” href=”healthmad.com/conditions-and-diseases/how-to-find-the-symptoms-of-prostate-cancer-and-prevention/” target=”_blank” title=”Symptoms of Prostate Cancer”>Symptoms of Prostate Cancer is rarely attack men under 45 years, except when any of your family who are suffering. The exact cause is unknown, but there are some things that can increase a person’s risk for prostate cancer are age and family history. Hormones, diet high in fat, and toxins, is also mentioned as risk factors for prostate cancer although the relation is not clear.

Some symptoms of prostate cancer should be aware, among them:

Difficulty urinatingThis may take the form you like the urge to urinate, but nothing is excluded, suspended in the middle, or often to the restroom. Other symptoms are difficult to stop, often in the form of urination many times or still feeling the urge to urinate even though in fact been completed.

Pain during urinationSimilarly, the problem is a tumor pressing the prostate urethra. however, pain during urination can also be symptoms of prostate infection known as prostatitis and benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland, but not cancer.

[removed]// [removed][removed]// 20) clearInterval(check5MinId); else { fiveMinChecks++; var fiveMinLoaded = false; var fiveMinPlayer = document.getElementById("SmartPlayer"); if (fiveMinPlayer) fiveMinLoaded = fiveMinPlayer[removed].indexOf(“undefined”) == -1; if (fiveMinLoaded) { clearInterval(check5MinId); if (document.getElementById(“titleseed”)) document.getElementById(“titleseed”).style.display = “block”; } } } var check5MinId = setInterval(“check5Min()”,250);// ]]>[removed]

Blood in urineThese symptoms are rare, but an excuse to go straight to the doctor. it is not always blood in significant amounts, perhaps you’ll see little red spots. Some forms of urinary tract infections can cause blood in the urine as well, but doctors must perform tests to distinguish.

Difficulty to obtain or maintain an erectionThis is one of the symptoms are very difficult to talk about. however, the erection does not occur when you want it or restrained in part, perhaps it’s time you checked out (your partner need to avoid this is smooth).

Blood in the semenThis sign like blood in the urine does not look so obvious. The number of blood is not too much, but enough to make semen pink and just a speck, according to men who had prostate cancer. The women also can help by considering additional colors found in semen after sex.

Chronic constipation and other bowel disordersThe prostate gland lies below the blood vessels and in front of the rectum, if there are tumors in here can affect the digestive function. So, it is like which comes first the chicken or the egg; chronic constipation can lead to an enlarged prostate because it causes enlargement of the gland, and vice versa. Chronic constipation and bowel disorders can be early indicator of colon cancer. if you experience symptoms of constipation, gas or other intestinal disorders do not blame your food, you should also consult a doctor.Want to pee in the middle of the nightThis is one of the disturbing symptoms for boys who are diagnosed with prostate cancer and they try to remember these symptoms. if you urinate more than once every night, you should visit a doctor and do the PSA test.Detection With urine testBritish researchers found that the protein contained in urine can be a strong indicator of a person at risk of prostate cancer. these findings in the future could be developed into a rapid test to know the symptoms of prostate cancer.

protein called Microseminoprotein-beta or MSMB found in low levels in men who are diagnosed with the disease. these proteins also appear to have lower doses in men with other types of cancer more aggressive.

These proteins are easy to detect because it was found in the urine and potentially will be a very simple test to identify men most at risk of prostate cancer.

The most effective screening tests available today are usually based on a single biomarker called prostate specific antigen (PSA). however, PSA tests are problematic because they have low specificity resulting in high false positive values ??and leads to surgical treatment and radiotherapy are not necessary.

At the current PSA test is the best method we have for detecting prostate cancer, but unfortunately have significant limitations. Given the limitations resulting from the PSA blood test, discovered a technique that more accurately diagnose prostate cancer is the core research on this disease. And accurate urine test that can be relied upon for prostate cancer will become an invaluable tool if it proves successful in large scale.

Tags: Cancer, Find, Prevention, Prostate, symptoms

Reduce Risk of p.falciparum

Symptom Advice — Mon, 25 Apr 2011 21:17:10 +0000

I would like to add a few more details to the response above. Intermittent Prevetive Treatment for pregnant women (IPTp) is especially relevant for women who have lived and continue to live in areas with malaria. they generally have been exposed to malaria before, and in many cases malaria has been detected in their placentas, but they can be completely asymptomatic (i.e. they have no symptoms) of malaria like fever etc. Researchers found that giving a course of an antimalarial treatment at specified time points, reduced maternal anaemia and the likelihood of having a low birth weight baby.

The recommended schedule for IPT in pregnant women is as follows:

SP shall be given as single adult dose (3 tablets of 500mg Sulphadoxineand 25mg Pyrimethamine each) at scheduled antenatal care visits during the second and third trimesters.

The two doses of SP shall be given at least one month apart.1st. Dose: at the first antenatal visit after quickening (first fetal movement – from sixteen weeks)2nd. Dose: at least one month after the first dose.

NOTE: HIV positive pregnant women shall receive at least 3 doses of SP instead of two doses (subsequent doses shall be given at least one month apart).

As the editor mentioned, IPT is also recommended by WHO, UNICEF and other international organizations. the following is an explanation of IPT in infants.

What is Intermittent Preventive Treatment of malaria in infants (IPTi)?

IPTi is the administration of an antimalarial drug at the time of childhood vaccinations in the first year of life and takes advantage of delivery alongside the well functioning WHO Expanded Programme for Immunisation (EPI). under this approach, infants receive an anti-malarial drug two or three times during the first year of life whether or not they have malaria and are provided with prophylactic protection for the duration the anti-malaria drug is present in the blood.

Why IPTi instead of chemoprophylaxis?

Continuous chemoprophylaxis in young children reduces malaria morbidity during the period of prophylaxis, however following the cessation of prophylaxis, a rebound of malaria was noted in the treatment group (Greenwood 1995, Menendez 1997), even though it is uncertain whether these children actually experienced more malaria than the children that received placebo when the whole period at risk was taken into account. Menendez et al gave weekly chemoprophylaxis to infants from 2 to 12 months of age which provided 60% protective efficacy against clinical malaria, however these children then experienced almost double the level of clinical malaria than the placebo group when the prophylaxis was stopped. when the children were followed up to 4 years of age the amount of malaria experienced by the two groups was similar (Aponte 2007). Due to the concern of a rebound in malaria, and because of the major logistic challenges involved in delivering weekly prophylaxis, and fears that large-scale drug use would hasten the spread of drug resistance, implementation did not occur in endemic countries.

How has Intermittent Preventive Treatment (IPT) developed as a treatment?

Continuous chemoprophylaxis was recommended for pregnant women to decrease the deleterious affects of malaria during pregnancy such as maternal anaemia resulting in low birth weight babies vulnerable to other infections. however, problems of delivery of the anti-malarial drug and compliance of the woman taking the anti-malarial drug on a regular basis greatly reduced the effectiveness of this strategy. however, high levels of African women visit antenatal clinics during their pregnancy and it was demonstrated that, delivery of a full course of an antimalarial treatment at specified time points regardless of the presence of parasites, reduced maternal anaemia and the likelihood of having a low birth weight baby – and the WHO recommends the use of IPT in pregnancy (IPTp) for malaria control.

With the success in preventing malaria morbidity using IPTp, it was decided to investigate IPT in infants (IPTi), taking advantage of the regular contacts that babies have with the clinic in the first year of life when their caregivers bring them in to receive vaccinationas delievered through the WHO’s Expanded Programme for Immunisation (EPI).

First results for IPTi:A study conducted in Ifakara, Tanzania of IPTi with sulfadoxine-pyrimethamine (SP), delivered at the time of the second and third doses of Diptheria-Tetanus-Pertussis/Oral Poliovirus Vaccine (DTP/OPV) and measles vaccination, at approximately 2, 3 and 9 months of age resulted in a 59% reduction in the incidence of clinical malaria and a 50% reduction in the incidence of severe anaemia (a PCV < 25%) in the first year of life (Schellenberg et al Lancet 2001). Infants who received IPTi-SP were also less likely to present as outpatients with fever and less likely to be admitted. Safety monitoring suggested no adverse consequences of IPTi-SP and serological analysis of the response to routine vaccinations was also reassuring. Infants who received IPTi-SP also had 36% less malaria in the second year of life (Schellenberg et al Lancet 2005).

Like or Dislike: 0 0